Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort.
Saved in:
| Title: | Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort. |
|---|---|
| Authors: | Trottier B; Département de Recherche, Clinique de Médecine Urbaine du Quartier Latin, Montreal, QC, Canada., Yang CJ; Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan., Watanabe D; AIDS Medical Center, NHO Osaka National Hospital, Osaka, Japan., Marchetti G; Department of Health Sciences, University of Milan, Milan, Italy., Elbirt D; Kaplan Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel., De Barra E; Department of International Health and Tropical Medicine, RCSI University of Medicine and Health Sciences, Beaumont Hospital, Dublin, Ireland., Gündüz A; Department of Infectious Diseases and Clinical Microbiology, Başakşehir Çam and Sakura City Training and Research Hospital, University of Health Sciences, Istanbul, Turkey., Lee SH; Department of Internal Medicine, Pusan National University School of Medicine and Pusan National University Hospital, Busan, Republic of Korea., Vogelmann R; Mannheimer Onkologie-Praxis, Mannheim, Germany.; Department of Medicine II, Medical Faculty Mannheim, University Medical Center Mannheim, Heidelberg University, Mannheim, Germany., Robineau O; EA2694, University of Lille, Centre Hospitalier de Tourcoing, Tourcoing, France., Choy CY; Department of Infectious Diseases, National Centre for Infectious Diseases (NCID), Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore., Berrevoets M; Department of Internal Medicine and Infectious Diseases, Elisabeth-TweeSteden Hospital, Tilburg, Netherlands., Uriel A; Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, UK., Thorpe D; Global HIV Medical Affairs, Gilead Sciences Europe Ltd, Uxbridge, UK., Heinzkill M; Medical Affairs, Gilead Sciences GmbH, Martinsried, Germany., Marongiu A; Real World Evidence, Gilead Sciences Europe Ltd, Stockley Park, Uxbridge, UK., Ramroth J; Real World Evidence, Gilead Sciences Europe Ltd, Stockley Park, Uxbridge, UK., D'Amato L; Clinical Operations, Gilead Sciences Srl, Milan, Italy., Mallolas J; HIV Unit, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. |
| Source: | HIV research & clinical practice [HIV Res Clin Pract] 2025 Dec; Vol. 26 (1), pp. 2456890. Date of Electronic Publication: 2025 Feb 12. |
| Publication Type: | Journal Article; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Group Country of Publication: England NLM ID: 101738312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2578-7470 (Electronic) Linking ISSN: 25787470 NLM ISO Abbreviation: HIV Res Clin Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2578-7470 |
|---|---|
| DOI: | 10.1080/25787489.2025.2456890 |
